US-based biotech company Cognito Therapeutics has raised $73 million in funding for the development of its non-invasive neuromodulation device for the treatment of neurodegenerative diseases including Alzheimer's.
This game changing device uses electromagnetic stimulation to target and improve brain function in patients with neurological conditions.
This funding round will aid the business with its ongoing clinical trials and accelerate the advancement of this exciting technology.
You can read the full article by Medical Device Network here: medicaldevice-network.com
Posted by:
Cure Talent